Latest

Sandisk's NAND Supercycle: Why I'm Calling For A Strong Buy Before Q3 Earnings (Archive)

NAND shortage and AI demand drive prices, margins, and cash flow higher.

24 Apr'26 Portfolio

The AI and capex trade

Siemens Energy: Sold Out Demand And Pricing Hikes

Bullish setup on AI-driven demand, grid upgrades, pricing power, and a chart breakout.

Nebius Q1 Preview: The Market Is Saying This Is An Outlier Among Outliers (Archive)

Nebius is chasing massive AI megadeals but must clear a daunting funding and execution hurdle.

Amazon Q1 Preview: Watch The Capex And EBIT Margins Print (Archive)

Amazon’s massive capex ramp, AI chips, and breakout chart clash with stretched valuation.

Lumentum: A Hidden Liquidity Risk Buried In The Footnotes (Archive)

Lumentum’s AI‑driven optics tailwinds are offset by a looming convertible‑debt liquidity overhang.

AMD: Why I'm Going From Very Bearish To Confidently Bullish (Archive)

AMD’s AI megadeals, MI355X leap, and agentic CPU boom now justify a strong buy.

Nvidia: Trading At A Rare Discount Just As Its Next AI Supercycle Kicks Off (Archive, Full Access)

Nvidia’s rare valuation discount collides with powerful AI-driven growth and technical momentum.

Hercules Capital: Big Commitments, Big Premium And Big Software Risk (Archive)

Hercules combines record growth with rich valuation and concentrated, potentially fragile software exposure.

Novo Nordisk: Is The GLP‑1 Golden Age Already Behind It? (Archive)

Novo Nordisk faces eroding GLP‑1 leadership, intensifying `1qcompetition, and mounting margin headwinds.

POET Technologies Has Consistently Chased Hype With Minimal Sales To Show For It (Archive, Full Access)

POET keeps chasing hot themes without delivering meaningful commercialization, revenues, or shareholder value.

SCHD: A Decent Buy But Not To Beat The Market (Archive)

SCHD: Fairly valued dividend ETF in a strong uptrend, but unlikely to beat SPY.

Credo: The Market Hasn't Fully Priced In The DustPhotonics Deal's Implications (Archive, Full Access)

DustPhotonics deal supercharges Credo’s optics growth, margins, and still-undervalued stock.

ServiceNow Q1 Preview: The Earnings Growth It Needs Is Too High To Justify A Buy (Archive)

AI disruption, healthy growth, and a demanding valuation hurdle shape my cautious ServiceNow view.